PRENW
Prenetics Holding Company LimitedNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-11.04
Beta
0.27
52W High
$0.07
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-63.10%
Forward P/E
—
PEG Ratio
—
About Prenetics Holding Company Limited
Prenetics Holding Company Limited is a leading global healthcare technology company focused on transforming health outcomes through advanced genetic testing and digital health solutions. With a robust portfolio that includes genetic screening and diagnostics, Prenetics leverages cutting-edge technologies and data analytics to facilitate personalized medicine and impactful health insights. As the demand for precision health solutions accelerates, the company is strategically expanding its offerings to capitalize on growth opportunities in an increasingly data-centric healthcare landscape.
Fundamentals
| Revenue (TTM) | $92.39M |
| Gross Profit (TTM) | $48.94M |
| EBITDA | $-32.97M |
| Operating Margin | -33.30% |
| Return on Equity | -31.80% |
| Return on Assets | -11.00% |
| Revenue/Share (TTM) | $6.57 |
| Book Value | $10.89 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 248.60% |
| Shares Outstanding | 0 |
| Float | $12.01M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
110.15%
HV 20-Day
84.47%
HV 30-Day
70.60%
HV 60-Day
113.55%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/14/2026